A6 peptide – Cancer Peptides

CD44 binding peptide derived from residues 136-143 of the connecting peptide domain of human urokinase plasminogen activator (uPA). Modulates CD44-mediated cell signalling but does not bind to the uPA receptor or interfere with the uPA/uPAR interaction. Inhibits migration, invasion, and metastasis of tumour cells in animal models.